Skip to main content

Table 2 Frequent gains and losses in chromosomal loci detected in relapsed and non-relapsed groups

From: Array comparative genomic hybridization analysis discloses chromosome copy number alterations as indicators of patient outcome in lymph node-negative breast cancer

 

No. of cases (%)

P

Loci

Genes

Relapsed group

Non-relapsed group

 

A. Gain

1q21.3

MLLT11

8 (42)

17 (53)

NS

1q22

MUC1

12 (63)

20 (63)

NS

ARHGEF2

11 (58)

20 (63)

NS

PMF1

10 (53)

17 (53)

NS

1q23.1

HAPLN2

11 (58)

18 (56)

NS

PRCC

11 (58)

19 (60)

NS

NTRK1

8 (42)

18 (56)

NS

1q32.1

PTPN7

11 (58)

18 (56)

NS

RBBP5

9 (47)

19 (60)

NS

PCTK3

8 (42)

17 (53)

NS

1q32.3

ATF3

7 (37)

18 (56)

NS

1q42.11

TP53BP2

8 (42)

16 (50)

NS

1q42.13

ABCB10

8 (42)

18 (56)

NS

1q44

AKT3

7 (37)

16 (50)

NS

3q29

MUC4

10 (53)

10 (31)

NS

8q24.3

BAI1

11 (58)

17 (53)

NS

PSCA

10 (53)

11 (34)

NS

16p13.3

ABCA3

13 (68)

19 (60)

NS

B. Loss

16q23.1

MAF

10 (53)

16 (50)

NS

  1. NS not significant, SD standard deviation